Psychiatry and Psychology Commons^™

Csf1r Regulates Schizophrenia-Related Stress Response And Vascular Association Of Microglia/Macrophages, Ling Yan, Yanli Li, Fengmei Fan, Mengzhuang Gou, Fangling Xuan, Wei Feng, Keerthana Chithanathan, Wei Li, Junchao Huang, Hongna Li, Wenjin Chen, Baopeng Tian, Zhiren Wang, Shuping Tan, Alexander Zharkovsky, L Elliot Hong, Yunlong Tan, Li Tian

Student and Faculty Publications

BACKGROUND: Microglia are known to regulate stress and anxiety in both humans and animal models. Psychosocial stress is the most common risk factor for the development of schizophrenia. However, how microglia/brain macrophages contribute to schizophrenia is not well established. We hypothesized that effector molecules expressed in microglia/macrophages were involved in schizophrenia via regulating stress susceptibility.

METHODS: We recruited a cohort of first episode schizophrenia (FES) patients (n = 51) and age- and sex-paired healthy controls (HCs) (n = 46) with evaluated stress perception. We performed blood RNA-sequencing (RNA-seq) and brain magnetic resonance imaging, and measured plasma level of colony stimulating …

Assessing The Effect Of Chronic Dopamine Receptor 2 Blockade As A Potential Model Of Secondary Negative Symptoms In Rats Using The Fr5/Chow Feeding Choice Task, Cyrene Nicholas

Honors Scholar Theses

Haloperidol, a dopamine (DA) D2 receptor antagonist, is an antipsychotic drug which is commonly used to treat schizophrenia and other psychiatric disorders. These disorders are often characterized by elevated striatal dopamine, which is speculated to have a role in producing positive symptoms such as hallucinations, delusions, and paranoia, as well as symptoms related to motivational salience and reward prediction. Individuals with schizophrenia also exhibit negative symptoms, such as amotivation, anergia, fatigue, and apathy among others. While some negative symptoms of schizophrenia are inherent to the pathophysiology, other negative symptoms are hypothesized to be partially induced by chronic exposure to antipsychotic …

Prospective Memory In Schizophrenia: Relationship To Medication Management Skills, Neurocognition And Symptoms In Individuals With Schizophrenia [Pre-Print], Sarah Raskin, Jacqueline Maye, Alexandra Rogers, David Correll, Marta Zamroziewicz, Matthew Kurtz

Faculty Scholarship

Objective: Impaired adherence to medication regimens is a serious concern for individuals with schizophrenia
linked to relapse and poorer outcomes. One possible reason for poor adherence to medication is
poor ability to remember future intentions, labeled prospective memory skills. It has been demonstrated
in several studies that individuals with schizophrenia have impairments in prospective memory that are
linked to everyday life skills. However, there have been no studies, to our knowledge, examining the
relationship of a clinical measure of prospective memory to medication management skills, a key element
of successful adherence. Methods: In this Study 41 individuals with schizophrenia and …